These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32642098)

  • 1. Genomic assessment distinguishes intrapulmonary metastases from synchronous primary lung cancers.
    Corsini EM; Wang J; Wu CC; Fujimoto J; Negrao MV; Chen R; Quek K; Mitchell KG; Chow CB; Little L; Gumbs C; Song X; Behrens C; Correa AM; Antonoff MB; Swisher SG; Heymach JV; Zhang J; Wistuba II; Futreal PA; Sepesi B; Zhang J
    J Thorac Dis; 2020 May; 12(5):1952-1959. PubMed ID: 32642098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
    Zheng R; Shen Q; Mardekian S; Solomides C; Wang ZX; Evans NR
    J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e71-e79. PubMed ID: 32007245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic lung cancer subtype differentiates synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases.
    Cheng H; Lei BF; Peng PJ; Lin YJ; Wang XJ
    J Surg Res; 2017 May; 211():215-222. PubMed ID: 28501120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathologic and molecular approach to staging of multiple lung nodules.
    Schneider F; Dacic S
    Transl Lung Cancer Res; 2017 Oct; 6(5):540-549. PubMed ID: 29114470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical Use of Genomic Profiling to Distinguish Intrapulmonary Metastases From Synchronous Primaries in Non-Small-Cell Lung Cancer: A Mini-Review.
    Klempner SJ; Ou SH; Costa DB; VanderLaan PA; Sanford EM; Schrock A; Gay L; Ali SM; Miller VA
    Clin Lung Cancer; 2015 Sep; 16(5):334-339.e1. PubMed ID: 25911330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma.
    Chen R; Li J; Fujimoto J; Hong L; Hu X; Quek K; Tang M; Mitra A; Behrens C; Chow CW; Jiang P; Little LD; Gumbs C; Song X; Zhang J; Tan D; Heymach JV; Wistuba I; Futreal PA; Gibbons DL; Byers LA; Zhang J; Reuben A
    J Exp Clin Cancer Res; 2022 May; 41(1):172. PubMed ID: 35546239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lineage tracing for multiple lung cancer by spatiotemporal heterogeneity using a multi-omics analysis method integrating genomic, transcriptomic, and immune-related features.
    Song Y; Zhou J; Zhao X; Zhang Y; Xu X; Zhang D; Pang J; Bao H; Ji Y; Zhan M; Wang Y; Ou Q; Hu J
    Front Oncol; 2023; 13():1237308. PubMed ID: 37799479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic heterogeneity of multiple synchronous lung cancer.
    Liu Y; Zhang J; Li L; Yin G; Zhang J; Zheng S; Cheung H; Wu N; Lu N; Mao X; Yang L; Zhang J; Zhang L; Seth S; Chen H; Song X; Liu K; Xie Y; Zhou L; Zhao C; Han N; Chen W; Zhang S; Chen L; Cai W; Li L; Shen M; Xu N; Cheng S; Yang H; Lee JJ; Correa A; Fujimoto J; Behrens C; Chow CW; William WN; Heymach JV; Hong WK; Swisher S; Wistuba II; Wang J; Lin D; Liu X; Futreal PA; Gao Y
    Nat Commun; 2016 Oct; 7():13200. PubMed ID: 27767028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment.
    Dacic S; Cao X; Bota-Rabassedas N; Sanchez-Espiridion B; Berezowska S; Han Y; Chung JH; Beasley MB; Dongmei L; Hwang D; Mino-Kenudson M; Minami Y; Papotti M; Rekhtman N; Roden AC; Thunnissen E; Tsao MS; Yatabe Y; Yoshida A; Wang L; Hartman DJ; Jerome JA; Kadara H; Chou TY; Wistuba II;
    J Thorac Oncol; 2024 Feb; 19(2):273-284. PubMed ID: 37717856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using molecular characteristics to distinguish multiple primary lung cancers and intrapulmonary metastases.
    Li Z; Lv H; Zhang F; Zhu Z; Guo Q; Wang M; Huang C; Guo L; Meng F; Tian Z
    PeerJ; 2024; 12():e16808. PubMed ID: 38313018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multidisciplinary approach for the differential diagnosis between multiple primary lung adenocarcinomas and intrapulmonary metastases.
    Belardinilli F; Pernazza A; Mahdavian Y; Cerbelli B; Bassi M; Gradilone A; Coppa A; Pignataro MG; Anile M; Venuta F; Della Rocca C; Giannini G; d'Amati G
    Pathol Res Pract; 2021 Apr; 220():153387. PubMed ID: 33647865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases.
    Girard N; Deshpande C; Lau C; Finley D; Rusch V; Pao W; Travis WD
    Am J Surg Pathol; 2009 Dec; 33(12):1752-64. PubMed ID: 19773638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-exome sequencing in a patient with synchronous triple primary malignancies involving lung cancer: a case report.
    Li D; Yu M; Zhou P; Yang J; Wang Y
    Precis Clin Med; 2020 Dec; 3(4):306-310. PubMed ID: 35692627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic profiling of synchronous triple primary tumors of the lung, thyroid and kidney in a young female patient: A case report.
    Peng L; Zeng Z; Teng X; Chen Z; Lin L; Bao H; Shao YW; Wang Y; Dong Y; Zhao Q
    Oncol Lett; 2018 Nov; 16(5):6089-6094. PubMed ID: 30344752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted deep sequencing helps distinguish independent primary tumors from intrapulmonary metastasis for lung cancer diagnosis.
    Liu J; Mao G; Li Y; Tao L; Wang W; Peng X; Wang J; Li X; Luan X; Luo R; Huang T; Zhang J; Xu M; Chen S; Wu D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2359-2367. PubMed ID: 32333141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Genomics to Differentiate Multiple Primaries From Metastatic Lung Cancer.
    Murphy SJ; Harris FR; Kosari F; Barreto Siqueira Parrilha Terra S; Nasir A; Johnson SH; Serla V; Smadbeck JB; Halling GC; Karagouga G; Sukov WR; Leventakos K; Yang P; Peikert T; Mansfield AS; Wigle DA; Yi ES; Kipp BR; Vasmatzis G; Aubry MC
    J Thorac Oncol; 2019 Sep; 14(9):1567-1582. PubMed ID: 31103780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer.
    Murphy SJ; Aubry MC; Harris FR; Halling GC; Johnson SH; Terra S; Drucker TM; Asiedu MK; Kipp BR; Yi ES; Peikert T; Yang P; Vasmatzis G; Wigle DA
    J Clin Oncol; 2014 Dec; 32(36):4050-8. PubMed ID: 25385739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis.
    Saab J; Zia H; Mathew S; Kluk M; Narula N; Fernandes H
    Transl Oncol; 2017 Jun; 10(3):442-449. PubMed ID: 28448960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Testing in Multiple Synchronous Lung Adenocarcinomas: Case Report and Literature Review.
    Rafael OC; Lazzaro R; Hasanovic A
    Int J Surg Pathol; 2016 Feb; 24(1):43-6. PubMed ID: 26350052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation patterns in small cell and non-small cell lung cancer patients suggest a different level of heterogeneity between primary and metastatic tumors.
    Saber A; Hiltermann TJN; Kok K; Terpstra MM; de Lange K; Timens W; Groen HJM; van den Berg A
    Carcinogenesis; 2017 Feb; 38(2):144-151. PubMed ID: 27993895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.